NewAmsterdam Pharma Company N.V. Gains 39.85%
Wed, Jan 10, 2024 at 07:33 PM
NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ) soared at $17.23, representing a gain of 39.9%. On Wed, Jan 10, 2024, NAMS:NASDAQ hit a New 2-Week High of $17.23. The stock got featured on our News Catalysts scanner on Mon, Jan 08, 2024 at 12:59 PM in the 'INVESTOR UPDATE' category. From Thu, Dec 28, 2023, the stock recorded 62.50% Up Days and 66.67% Green Days
About NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ)
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 300%
- Nauticus Robotics Inc. (KITT:NASDAQ), 78.65%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 61.19%
- Vinco Ventures Inc. (BBIG:NASDAQ), 57.14%
- NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ), 39.85%
- Sana Biotechnology, Inc. (SANA:NASDAQ), 39.28%
- Top KingWin Ltd (TCJH:NASDAQ), 38.55%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 37.21%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 36.53%
- Roma Green Finance Limited (ROMA:NASDAQ), 36.21%